I-Mab to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference
Rhea-AI Summary
I-Mab (NASDAQ: IMAB), a U.S.-based global biotech company specializing in precision immuno-oncology agents for cancer treatment, has announced its participation in Oppenheimer's 35th Annual Healthcare Life Sciences Conference. The virtual conference is scheduled for February 11-12, 2025.
The company's management team will deliver a presentation on Tuesday, February 11, 2025, from 4:00 to 4:30 PM ET. The presentation will be accessible via webcast, and the company will also participate in one-on-one meetings during the conference.
Positive
- None.
Negative
- None.
News Market Reaction – IMAB
On the day this news was published, IMAB gained 0.94%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
ROCKVILLE, Md., Feb. 04, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ: IMAB) (the Company), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer, today announced that I-Mab’s management team will participate in Oppenheimer’s 35th Annual Healthcare Life Sciences Conference, being held virtually, on February 11-12, 2025.
Details are as follows:
| Oppenheimer’s 35th Annual Healthcare Life Sciences Conference | ||
| Conference Date: | February 11-12, 2025 | |
| Format: | Company Presentation and one-on-one meetings | |
| Presentation Time: | Tuesday, February 11, 2025, 4:00 to 4:30 PM ET | |
| Webcast Link: | https://wsw.com/webcast/oppenheimer39/imab/2739496 | |
About I-Mab
I-Mab (NASDAQ: IMAB) is a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment of cancer. I-Mab has established operations in the U.S. in Rockville, Maryland, and Short Hills, New Jersey. For more information, please visit us at: https://www.i-mabbiopharma.com/ and follow us on LinkedIn and X.
Investor & Media Contacts
PJ Kelleher
LifeSci Advisors
+1 617-430-7579
pkelleher@lifesciadvisors.com
FAQ
When is I-Mab (IMAB) presenting at the Oppenheimer Healthcare Conference 2025?
How can investors watch I-Mab's presentation at the Oppenheimer Conference?
What type of meetings will I-Mab participate in at the Oppenheimer Conference 2025?
Is the Oppenheimer Healthcare Conference 2025 virtual or in-person?
What is I-Mab's primary business focus according to the conference announcement?
